Revenue: The sum of all revenue fields included for a company's operating activities.
Novartis AG (NVS) had Revenue of $14.36B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$14.36B |
$3.93B |
|
$3.54B |
|
$10.82B |
|
$9.86B |
|
$4.50B |
|
$-305.00M |
|
$4.20B |
|
$4.20B |
|
$3.93B |
|
$3.93B |
|
$3.93B |
|
$3.93B |
|
$4.50B |
|
$4.50B |
|
1.93B |
|
1.94B |
|
$2.04 |
|
$2.02 |
|
| Balance Sheet Financials | |
$28.20B |
|
$10.48B |
|
$79.09B |
|
$107.29B |
|
$32.00B |
|
$22.60B |
|
$30.54B |
|
$62.54B |
|
$44.75B |
|
$-9.84B |
|
$44.75B |
|
-- |
|
| Cash Flow Statement Financials | |
$16.88B |
|
$-2.77B |
|
$-16.55B |
|
$11.46B |
|
$9.56B |
|
$-1.90B |
|
$797.00M |
|
$-7.82B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
0.34 |
|
0.67 |
|
75.35% |
|
31.35% |
|
31.35% |
|
-- |
|
29.22% |
|
27.36% |
|
$15.95B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.55 |
|
1.60 |
|
56.31 |
|
8.78% |
|
-39.96% |
|
3.66% |
|
5.84% |
|
-- |
|
$8.22 |
|
$8.70 |
|